USD 0.0
(-90.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - USD | -100.0% |
2022 | 7375.00 USD | -81.65% |
2021 | 40.19 Thousand USD | -83.36% |
2020 | 241.62 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2014 | 4083.00 USD | 0.0% |
2013 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 FY | - USD | -100.0% |
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 100.0% |
2022 Q2 | - USD | -100.0% |
2022 Q1 | 375.00 USD | 35.87% |
2022 FY | 7375.00 USD | -81.65% |
2022 Q4 | -7000.00 USD | -200.0% |
2022 Q3 | 7000.00 USD | 0.0% |
2021 FY | 40.19 Thousand USD | -83.36% |
2021 Q3 | 2460.00 USD | -88.86% |
2021 Q4 | 276.00 USD | -88.78% |
2021 Q2 | 22.07 Thousand USD | 43.48% |
2021 Q1 | 15.38 Thousand USD | -93.63% |
2020 FY | 241.62 Thousand USD | 0.0% |
2020 Q4 | 241.62 Thousand USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 Q1 | 1575.00 USD | 0.0% |
2014 Q4 | - USD | -100.0% |
2014 Q3 | 386.00 USD | -81.81% |
2014 Q2 | 2122.00 USD | 34.73% |
2014 FY | 4083.00 USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Bio Medica Corporation | 913 Thousand USD | 100.0% |
Arrayit Corporation | 4.37 Million USD | 100.0% |
Atlantic International Corp. | - USD | NaN% |
Biocept, Inc. | 25.85 Million USD | 100.0% |
Bioqual, Inc. | 58.59 Million USD | 100.0% |
CardioGenics Holdings Inc | - USD | NaN% |
DermTech, Inc. | 15.29 Million USD | 100.0% |
Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 100.0% |
HTG Molecular Diagnostics, Inc. | 6.36 Million USD | 100.0% |
iMD Companies, Inc. | - USD | NaN% |
IDenta Corp. | 1.05 Million USD | 100.0% |
Interpace Biosciences, Inc. | 40.21 Million USD | 100.0% |
Integrative Health Technologies, Inc. | 447.49 Thousand USD | 100.0% |
InVitro International | 792.62 Thousand USD | 100.0% |
Lumos Diagnostics Holdings Limited | 11.13 Million USD | 100.0% |
Many Bright Ideas Technologies Inc. | - USD | NaN% |
Medical Imaging Corp. | 7.22 Million USD | 100.0% |
NovelStem International Corp. | 12 Thousand USD | 100.0% |
Optigenex Inc. | 465.97 Thousand USD | 100.0% |
PharmChem, Inc. | 6.01 Million USD | 100.0% |
Proteome Sciences plc | 6.4 Million USD | 100.0% |
Response Genetics, Inc | 18.04 Million USD | 100.0% |
Rennova Health, Inc. | 13.03 Million USD | 100.0% |
RushNet, Inc. | 1.78 Million USD | 100.0% |
ScreenPro Security Inc. | 1.91 Million USD | 100.0% |
Stella Diagnostics Inc. | - USD | NaN% |
StageZero Life Sciences Ltd. | 3.79 Million USD | 100.0% |
Todos Medical Ltd. | 7.69 Million USD | 100.0% |